Page last updated: 2024-09-04

vx 497 and shikonin

vx 497 has been researched along with shikonin in 1 studies

Compound Research Comparison

Studies
(vx 497)
Trials
(vx 497)
Recent Studies (post-2010)
(vx 497)
Studies
(shikonin)
Trials
(shikonin)
Recent Studies (post-2010) (shikonin)
25376602505

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)shikonin (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.1392
DNA topoisomerase 2-alphaHomo sapiens (human)6.6
Pyruvate kinase PKMHomo sapiens (human)6.2933
M-phase inducer phosphatase 1Homo sapiens (human)0.22
M-phase inducer phosphatase 2Homo sapiens (human)0.4
DNA topoisomerase 2-betaHomo sapiens (human)6.6
Class A sortase SrtA Staphylococcus aureus2.65

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vx 497 and shikonin

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023